HUTCHMED completes enrollment of global Phase III SAFFRON trial for ORPATHYS and TAGRISSO combination in lung cancer

Spinogenix reveals positive SPG302 topline results from Phase 2a study for treatment of ALS

iLeukon reports FDA clearance of IND application for phase II study of ILKN421H in advanced NSCLC

AVEO Oncology signs development and option agreement with HiberCell

Merck assumes full development rights for investigational antibody MK-8690

Merck secures USD700m R&D funding from Blackstone Life Sciences for cancer drug sacituzumab tirumotecan

Arctic Bioscience reports significant anti-inflammatory effects from psoriasis drug candidate HRO350 in phase 2b trial

UCB's KYGEVVI receives FDA approval for TK2d treatment

Camurus launches Oczyesa in Germany for patients with acromegaly

Zhimeng starts CB03-154 phase 2/3 clinical trial

Akeso's ivonescimab in combination with chemotherapy granted Breakthrough Therapy Designation in China

GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine

Kiora Pharmaceuticals joins Global Genes' RARE-X Vision Consortium

Pilatus Biosciences to present new preclinical data on PLT012 at SITC 2025

Rovia Clinical Research opens new clinical research site in Hattiesburg, Mississippi